This page lists the SEC filings reported by Quaker BioVentures II LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2012-02-17 | Quaker BioVentures II LP | CEMPRA, INC. | 3,300,601 | - | EDGAR |
| SC 13G/A | 2012-02-14 | Quaker BioVentures II LP | INSMED INC | 2,189,994 | - | EDGAR |
| SC 13G/A | 2012-02-14 | Quaker BioVentures II LP | NUPATHE INC. | 2,830,706 | - | EDGAR |
| SC 13G/A | 2012-02-14 | Quaker BioVentures II LP | ACHILLION PHARMACEUTICALS INC | - | - | EDGAR |
| SC 13G | 2011-03-11 | Quaker BioVentures II LP | INSMED INC | 1,861,494 | - | EDGAR |
| SC 13G | 2011-02-15 | Quaker BioVentures II LP | NUPATHE INC. | 2,830,706 | - | EDGAR |
| SC 13G | 2010-08-30 | Quaker BioVentures II LP | ACHILLION PHARMACEUTICALS INC | - | - | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.